Two Sigma Investments’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Sell |
58,965
-91,309
| -61% | -$628K | ﹤0.01% | 2623 |
|
|
2025
Q1 | $433K | Sell |
150,274
-19,268
| -11% | -$55.5K | ﹤0.01% | 2525 |
|
|
2024
Q4 | $797K | Sell |
169,542
-102,565
| -38% | -$482K | ﹤0.01% | 2249 |
|
|
2024
Q3 | $971K | Sell |
272,107
-237,581
| -47% | -$848K | ﹤0.01% | 2084 |
|
|
2024
Q2 | $3.16M | Buy |
509,688
+334,464
| +191% | +$2.07M | 0.01% | 1190 |
|
|
2024
Q1 | $1.65M | Sell |
175,224
-86,528
| -33% | -$817K | ﹤0.01% | 1553 |
|
|
2023
Q4 | $1.77M | Sell |
261,752
-300,371
| -53% | -$2.03M | ﹤0.01% | 1610 |
|
|
2023
Q3 | $2.5M | Sell |
562,123
-15,743
| -3% | -$69.9K | 0.01% | 1185 |
|
|
2023
Q2 | $1.91M | Sell |
577,866
-71,944
| -11% | -$237K | ﹤0.01% | 1395 |
|
|
2023
Q1 | $1.85M | Buy |
649,810
+516,791
| +389% | +$1.47M | 0.01% | 1359 |
|
|
2022
Q4 | $968K | Buy |
+133,019
| New | +$968K | ﹤0.01% | 1654 |
|
|
2022
Q3 | – | Sell |
-214,763
| Closed | -$1.05M | – | 2532 |
|
|
2022
Q2 | $1.05M | Buy |
214,763
+197,863
| +1,171% | +$969K | ﹤0.01% | 1469 |
|
|
2022
Q1 | $400K | Sell |
16,900
-504,090
| -97% | -$11.9M | ﹤0.01% | 2079 |
|
|
2021
Q4 | $9.22M | Sell |
520,990
-111,549
| -18% | -$1.97M | 0.02% | 672 |
|
|
2021
Q3 | $17.8M | Buy |
632,539
+616,928
| +3,952% | +$17.4M | 0.04% | 435 |
|
|
2021
Q2 | $164K | Buy |
15,611
+1,632
| +12% | +$17.1K | ﹤0.01% | 2261 |
|
|
2021
Q1 | $165K | Sell |
13,979
-13,668
| -49% | -$161K | ﹤0.01% | 2193 |
|
|
2020
Q4 | $324K | Buy |
27,647
+16,147
| +140% | +$189K | ﹤0.01% | 1706 |
|
|
2020
Q3 | $91K | Buy |
+11,500
| New | +$91K | ﹤0.01% | 1767 |
|